Eleni Bibaki

558 total citations
16 papers, 370 citations indexed

About

Eleni Bibaki is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Eleni Bibaki has authored 16 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in Eleni Bibaki's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Respiratory Support and Mechanisms (3 papers). Eleni Bibaki is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Respiratory Support and Mechanisms (3 papers). Eleni Bibaki collaborates with scholars based in Greece, United Kingdom and Netherlands. Eleni Bibaki's co-authors include Κατερίνα Αντωνίου, Athina Trachalaki, Eirini Vasarmidi, Eliza Tsitoura, Nikos Tzanakis, George Margaritopoulos, Athol U. Wells, Demetrios�� Spandidos, Νikolaos Tzanakis and Ismini Lasithiotaki and has published in prestigious journals such as Frontiers in Immunology, Oncotarget and Respiratory Medicine.

In The Last Decade

Eleni Bibaki

16 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eleni Bibaki Greece 10 261 102 82 47 42 16 370
Athina Trachalaki Greece 12 298 1.1× 117 1.1× 95 1.2× 52 1.1× 57 1.4× 23 444
Supparerk Disayabutr Thailand 5 303 1.2× 73 0.7× 102 1.2× 43 0.9× 21 0.5× 11 393
Peter Heukels Netherlands 8 465 1.8× 103 1.0× 93 1.1× 40 0.9× 74 1.8× 13 537
Xianhua Gui China 12 193 0.7× 82 0.8× 49 0.6× 95 2.0× 52 1.2× 27 355
Takuma Isshiki Japan 14 283 1.1× 75 0.7× 160 2.0× 65 1.4× 76 1.8× 41 464
Nariaki Kokuho Japan 11 243 0.9× 45 0.4× 57 0.7× 39 0.8× 25 0.6× 24 316
Anastassios V. Koutsopoulos Greece 7 253 1.0× 66 0.6× 45 0.5× 63 1.3× 27 0.6× 7 351
C. Sanfiorenzo France 8 183 0.7× 170 1.7× 44 0.5× 18 0.4× 43 1.0× 14 415
Rekha Badiger United Kingdom 6 88 0.3× 89 0.9× 28 0.3× 43 0.9× 93 2.2× 9 308

Countries citing papers authored by Eleni Bibaki

Since Specialization
Citations

This map shows the geographic impact of Eleni Bibaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleni Bibaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleni Bibaki more than expected).

Fields of papers citing papers by Eleni Bibaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleni Bibaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleni Bibaki. The network helps show where Eleni Bibaki may publish in the future.

Co-authorship network of co-authors of Eleni Bibaki

This figure shows the co-authorship network connecting the top 25 collaborators of Eleni Bibaki. A scholar is included among the top collaborators of Eleni Bibaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleni Bibaki. Eleni Bibaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pantazopoulos, Ioannis, Georgios Mavrovounis, Nikolaos Papagiannakis, et al.. (2024). Nasal high flow or noninvasive ventilation? navigating hypercapnic COPD exacerbation treatment: A randomized noninferiority clinical trial. Respiratory Medicine. 232. 107762–107762. 4 indexed citations
2.
Trachalaki, Athina, Eliza Tsitoura, Rachele Invernizzi, et al.. (2021). Enhanced IL-1β Release Following NLRP3 and AIM2 Inflammasome Stimulation Is Linked to mtROS in Airway Macrophages in Pulmonary Fibrosis. Frontiers in Immunology. 12. 661811–661811. 52 indexed citations
3.
Bibaki, Eleni, Ioannis Pantazopoulos, Nikolaos Athanasiou, et al.. (2020). Nasal high-flow oxygenversusnoninvasive ventilation in acute exacerbation of COPD: protocol for a randomised noninferiority clinical trial. ERJ Open Research. 6(4). 114–2020. 3 indexed citations
4.
Αντωνίου, Κατερίνα, Katerina Markopoulou, Argyrios Tzouvelekis, et al.. (2020). Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study. ERJ Open Research. 6(1). 172–2019. 46 indexed citations
5.
Tsitoura, Eliza, Eleni Bibaki, Maria Bolaki, et al.. (2020). [Comment] Treatment strategies to fight the new coronavirus SARS-CoV-2: A challenge for a Rubik's Cube solver. Experimental and Therapeutic Medicine. 20(1). 147–150. 9 indexed citations
6.
Tsitoura, Eliza, Eirini Vasarmidi, Eleni Bibaki, et al.. (2019). Accumulation of damaged mitochondria in alveolar macrophages with reduced OXPHOS related gene expression in IPF. Respiratory Research. 20(1). 264–264. 41 indexed citations
7.
Bibaki, Eleni, Eirini Vasarmidi, Athina Trachalaki, et al.. (2019). CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer. PA1306–PA1306. 1 indexed citations
8.
Vasarmidi, Eirini, Eleni Bibaki, Athina Trachalaki, et al.. (2019). Evaluation of CD163 expression on alveolar macrophages from BAL of patients with Fibrotic Lung Diseases. PA4694–PA4694. 2 indexed citations
9.
Αντωνίου, Κατερίνα, Konstantinos Karagiannis, Eliza Tsitoura, et al.. (2018). Clinical applications of mesenchymal stem cells in chronic lung diseases (Review). Biomedical Reports. 8(4). 314–318. 29 indexed citations
10.
Margaritopoulos, George, Athina Trachalaki, Athol U. Wells, et al.. (2018). Pirfenidone improves survival in IPF: results from a real-life study. BMC Pulmonary Medicine. 18(1). 177–177. 71 indexed citations
11.
Bibaki, Eleni, Eliza Tsitoura, Eirini Vasarmidi, et al.. (2018). miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns. Molecular Medicine Reports. 17(5). 7105–7112. 27 indexed citations
12.
Vasarmidi, Eirini, Athina Trachalaki, George Margaritopoulos, et al.. (2018). Investigation of key autophagy-and mitophagy-related proteins and gene expression in BALF cells from patients with IPF and RA-ILD. Molecular Medicine Reports. 18(4). 3891–3897. 12 indexed citations
13.
Samara, Katerina, Athina Trachalaki, Eliza Tsitoura, et al.. (2017). Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis. Respiratory Research. 18(1). 218–218. 48 indexed citations
14.
Kahn, Nicolas, Laura Fregonese, Míriam Barrecheguren, et al.. (2017). Clinical highlights from the 2016 European Respiratory Society International Congress. ERJ Open Research. 3(2). 147–2016. 1 indexed citations
15.
Bibaki, Eleni, et al.. (2017). The expression of miR185, miR29a and their targets in IPF and lung cancer (LC). A BALF study. OA480–OA480. 1 indexed citations
16.
Tsitoura, Eliza, Athol U. Wells, Konstantinos Karagiannis, et al.. (2016). MiR-185/AKT and miR-29a/Collagen 1a pathways are activated in IPF BAL cells. Oncotarget. 7(46). 74569–74581. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026